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ABSTRACT 
Objective: Five different epidemiologic patterns (very high, high, 
intermediate, low, and very low) become apparent when inci- 
dence rates and prevalence of age-specific antibodies to 
hepatitis A virus (HAV) (anti-HA) are examined. This study eval- 
uated the age distribution of the prevalence of immunity to HAV 
in neonates and very young Indonesian children. 
Methods: The study population (n = 153) included neonates, from 
Indonesia, who were followed over 62 months. Sera were col- 
lected at birth and at months 1, 2, 12, 14, 24, 36, 48, 60, and 
62. The HAV antibodies were determined by radioimmunoassay. 
Results: At birth almost all the children (96.8%) were anti-HA 
positive, having antibodies passively acquired from their moth- 
ers. They all became negative in the following 12 months, At 
the age of 1 year, 0.9% of the infants showed a positive serol- 
ogy for anti-HA. The percentage of children who acquired a nat- 
ural immunization by HAV infections rose to 4.7% at the age 
of 2 years, 11.4% at 3 years, 20.3% at 4 years, and finally, 
36.4% at 5 years of age. 
Discussion: Indonesia shows the pattern of a highly endemic 
area. More improvements in public health and sanitation can 
raise the age of infection in Indonesia. This epidemiologic shift 
may increase the probability of future epidemics of HAV in 
groups previously protected by immunity acquired in early child- 
hood. This new epidemiologic pattern may have clinical and 
public health implications, because of the relatively large groups 
of older, unprotected individuals living in an environment that 
is still contaminated. 
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The hepatitis A virus (HAV) was ftst discovered in 1973.l 
Hepatitis A is the inflammatory disease of the liver caused 
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by this virus. The hepatitis A infection is widespread 
throughout the world, its occurrence and age-dependence 
are determined, to a large extent, by environmental and 
socioeconomic conditions. By far the most common 
mode of HAV transmission (>95%) is through the fecal- 
oral route.* Infection is usually acquired through the 
ingestion of viral particles as a result of the contamina- 
tion of hands, food, or water with fecal matter. Following 
an incubation period of between 15 and 50 days, in gen- 
eral 10% of infected subjects develop clinical hepatitis, 
and in 90% the infection is subclinical.3 Unlike the clini- 
cal course, the infection is usually self-limited, leading to 
immunity in 1 to 3 months. 
In past decades, the pattern of HAV infections has 
changed.4-6 Paradoxically, higher standards of hygiene 
have increased the incidence of HAV infections in adults, 
because fewer and fewer people acquire immunity dur- 
ing childhood. Because age plays a significant role in the 
severity of HAV disease, the expression of clinical disease 
is highly age-related.Thus, this shift of infection to older 
age groups will increase the number of clinical infections 
in many developing countries.6 In children under the age 
of 6 years, less than 10% become jaundiced,7*8 a per- 
centage that rises to 60 to 80% in adults.8 Hepatitis A 
virus infection does not lead to chronic infection, chronic 
carrier state, or chronic sequelae.The infection rarely has 
a fulminant evolution. 
Worldwide, an estimated 1.4 million cases of hepati- 
tis A are reported annually.The highest figures are found 
in Asia, Africa, and Eastern Europe.6 But since reporting 
is often incomplete, the true incidence may be 3 to 10 
times higher (unpublished data).6 Five different epi- 
demiologic patterns (very high, high, intermediate, low, 
and very low) become apparent when incidence rates 
and prevalence of age-specific antibodies to HAV (anti- 
HA) are examined.GThese patterns correlate closely with 
the socioeconomic and hygiene conditions in each of 
the geographic areas. 
This study evaluated the age distribution of the preva- 
lence of immunity to HAYV in neonates and very young 
Indonesian children. 
MATERIAL AND METHODS 
The study population (n = 153) included neonates, from 
the Bandung area in Indonesia, who were followed over 
31 
32 international Journal of Infectious Diseases / Volume 2, Number 1, July 1997 
62 months. Sera were collected at birth and at months 1, 
2, 12, 14, 24, 36, 48,60, and 62. The HAV markers (anti- 
HA/IgM and anti-HA/IgG) were determined by radio- 
immunoassay (RIA), using commercially available kits 
(Abbott Laboratories, Chicago, USA, and Sorin Biomedica, 
Saluggia (Vercelli), Italy). 
The sera from the newborns and their mothers were 
collected at birth, in 1987 and 1988. During the 5-year fol- 
low-up, sera were collected from the infantsAll sera were 
stored at -80°C. 
RESULTS 
At birth almost all the children (96.8%) were anti-HA pos- 
itive; they had antibodies passively acquired from their 
mothers. They all became negative in the following 12 
months. At the age of 1 year, 0.9% of the infants again 
showed a positive serology for anti-HA.The numbers of 
children who acquired a natural immunization by HA&’ 
infections rose to 4.7% at the age of 2 years, 11.4% at 3 
years, 20.3% at 4 years, and finally, 36.4% at 5 years of 
age (Figure 1). In 9.6% of the cases of seroconversion, anti- 
HA/IgM were also detectable. 
Extrapolation of this data to the situation of mothers 
(young adults) shows that more than 90% of the children 
will have developed anti-HA antibodies by the age of 10 
yearsThis pattern is typical for a highly endemic area.The 
difference between very young children in highly 
endemic countries and those in countries with low 
endemicity emerge only beyond the age of 36 months. 
At this age, children generally start having multiple con- 
tacts with the world outside the family (Figure 2). 
DISCUSSION 
The improvement of sociohygienic standards has de- 
creased the circulation of HAV in the past 20 yearsThe 
reduction in the circulation of HAV implies that an 
increasing number of adults are more susceptible to the 
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Figure 1. Anti-HA in Indonesian neonates and young children by age. 
Figure 2. Comparison of hepatitis A virus endemicity between 
Indonesia and Belgium. 
infection than in the past and epidemics may occur in 
previously “immune” areas. 
Findings of this study indicate that the seroepidemio- 
logic pattern of HAV in Indonesia is not that of the poor- 
est developing countries, which are characterized by a 
rapid acquisition of HAV at a very young age, with over 
90% of children infected by the time they are 5 years 
old.6 But Indonesia shows the pattern of a highly endemic 
area, typical of countries where hygiene conditions are 
slightly better. Fewer children are infected by the age of 
5 years, but more than 90% will have developed anti-HA 
antibodies by the age of 10 years.& 
More improvements in public health and sanitation 
can raise the age of infection in Indonesia.This epidemio- 
logic shift can increase the probability of future epide- 
mics of HAV in groups previously protected by immunity 
acquired in early childhood.This new epidemiologic pat- 
tern may have clinical and public health implications, 
because of the relatively large groups of unprotected indi- 
viduals living in an environment that is still contaminated. 
Because age plays a significant role in the severity of HAV 
infections and diseases, this situation may give rise to 
more severe cases of clinical disease.This evolution is 
illustrated by findings in Thailand and on some French 
Polynesian islands in the Pacific.‘,‘O 
In this context, if an inexpensive vaccine becomes 
available, vaccination may become a suitable public health 
strategy to protect susceptible populations (i.e., school- 
children, adolescents, and young adults). However, vacci- 
nation cannot be the only strategy to prevent HAV” It is 
imperative that much-needed measures be taken to 
improve sanitation, such as safer water supply, control of 
shellfish beds, and adherence to strict sanitary techniques 
by food handlers and food industries. 
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